![\"\"](\"\/wp-content\/uploads\/2025\/12\/in-article-unified-quality-case-study-richter-biologics-image-1.png\")
<\/p>\n\nA few years ago, following robust growth, Richter BioLogics faced a choice: it could either continue managing quality operations through manual, paper-based processes or it could seek to standardize site execution.\n<\/p>\n
\nThe CDMO decided to modernize and adopted ³Ô¹Ï±¬ÁÏ Quality Cloud to enable growth, improve compliance, and deliver more customer value. Through its partnership with ³Ô¹Ï±¬ÁÏ, Richter BioLogics has unified quality management, documents, and training on a single platform. Modernizing quality in this way has freed up capacity equivalent to four full-time team members for strategic work.\n<\/p>\n
\nEquipped with systems that are able to scale with business needs, Richter BioLogics found that production increased threefold after it opened a new manufacturing site in Bovenau, Germany, in 2024. Critically, expansion did not entail more paper. Customer confidence is also growing, providing a competitive edge that helps to win business.\n<\/p>\n
\nPartnering with companies ranging from small biotechs to global biopharmas, Richter BioLogics provides support as products move from clinical development to commercial manufacturing.\n<\/p>\n
\nPaper-based workflows introduce risks to efficiency and compliance when serving a diverse customer base. Inspections, which are carried out both by local authorities and international bodies such as the FDA and ANVISA, add to the pressure. Birte Mueller, team lead GMP compliance at Richter BioLogics, and her team realized that laborious processes involving manual handovers between sites was not a scalable approach long term.\n<\/p>\n
\nEveryday frictions slow down manufacturing. Given its ambitions to scale manufacturing capacity, Mueller knew this would eventually constrain the business. \u201cIf we had a deviation and an ongoing failure investigation, we had to scan the paper, then email it. Colleagues at our Hamburg site would print it out and scan it again before we printed it again to have it on paper,\u201d she says.\n<\/p>\n
\nComplex processes also create reporting and visibility challenges for CDMOs. Each customer has a unique set of reporting and communication demands, making it difficult to manage efficiently. \u201cSome customers want to be informed when the deviation occurs, some want to be informed every week about the status of quality events, and others only want to be informed once a month or per batch,\u201d explains Mueller.\n<\/p>\n
\nA manual approach to document management and training reduced capacity for higher value work. The lack of traceability during training also posed a potential compliance risk by making it difficult to monitor training status.\n<\/p>\n
\nTo ensure efficiency and compliance, Richter BioLogics adopted a digital-first approach to quality processes, documents, and training.\n<\/p>\n
\nThe partnership with ³Ô¹Ï±¬ÁÏ began in 2019 with ³Ô¹Ï±¬ÁÏ QMS, which was initially implemented to manage deviations, change controls, audits, and CAPAs. In 2023, building on this success, the company made a strategic decision to implement ³Ô¹Ï±¬ÁÏ QualityDocs and ³Ô¹Ï±¬ÁÏ Training.\n<\/p>\n
\nIn choosing ³Ô¹Ï±¬ÁÏ Quality Cloud, Richter BioLogics felt confident it was using a platform trusted by regulatory authorities and customers, as demonstrated by positive feedback during inspections and site visits.\n<\/p>\n
\n\u201cSome potential customers at one of our sites asked us about our quality system. After they heard we use ³Ô¹Ï±¬ÁÏ Quality Cloud, they said \u2018Okay, we don’t need to talk about the quality stuff anymore, we can talk about the manufacturing\u2019. This is a real benefit for CDMOs,\u201d Mueller explains.\n<\/p>\n
\nSince then, Richter BioLogics has significantly reduced its reliance on paper: opening a new site in Bovenau led to three times more production without entailing three times more paper. Managing a single platform has lessened the maintenance burden since all quality systems are connected and use the same metadata.\n<\/p>\n
\nBy unifying quality systems, Richter BioLogics has achieved significant productivity gains. Eliminating manual work and trackers has increased capacity equivalent to four full-time team members and freed time to focus on higher-value tasks that directly impact company growth.\n<\/p>\n
<\/p>\n
\nUsing ³Ô¹Ï±¬ÁÏ QMS, Richter BioLogics has streamlined previously manual processes (such as deviations), which improves audit readiness and avoids unnecessary delays during the manufacturing process. Because the team benefits from real-time status on quality events, it\u2019s becoming easier to address customer requests using pre-defined reports. Simplified reporting also streamlines batch release preparations and boosts overall compliance.\n<\/p>\n
\nA quick transition to ³Ô¹Ï±¬ÁÏ QualityDocs resulted in minimal business impact. In just a few days, the team migrated over 5,000 documents to ³Ô¹Ï±¬ÁÏ Quality Cloud. To make it easier to update templates as the company scales its manufacturing, Richter BioLogics follows ³Ô¹Ï±¬ÁÏ industry best practices and uses out-of-the-box workflows instead of customization.\n<\/p>\n
\nMoving 400 people from a paper-based model to ³Ô¹Ï±¬ÁÏ Training presented a steeper learning curve. However, the company is already seeing tangible benefits. \u201cWe now have defined training metrics and can report on different kinds of topics, such as who is trained in a specific record or the training status of the core team. This makes completing the checks during batch record review much easier,\u201d says Mueller.\n<\/p>\n
\nRichter BioLogics is planning to introduce external collaboration capabilities as the next phase of its quality transformation. Sponsors will gain direct access to its quality system, improving real-time collaboration, communication, and compliance throughout the manufacturing process.\n<\/p>\n
\nStronger partnerships will ultimately deliver more value to the industry. For Mueller and her team, that is what matters most.\n<\/p>\n